cardi care logo

CardiaCare Completes Seed Extension Raise to Support Clinical Pilot Studies


REHOVOT, Israel, Sept. 18, 2023 /PRNewswire/ — CardiaCare, a medical device company developing a breakthrough wearable technology for detecting, monitoring, and non-invasively treating cardiac arrhythmias using drug-free neuromodulation, recently closed an over-subscribed Seed Extension round. The financing was led by Solardis Health Ventures and supports efforts to expand the technology’s clinical program for multiple indications related to treating Atrial Fibrillation (AFib). CardiaCare’s platform can simultaneously help physicians remotely monitor their patients and create dynamic, personalized neuromodulation treatments based on the real-time patient’s condition data. CardiaCare’s mission is to become the new standard of care all-in-one therapeutic monitoring platform for cardiac arrhythmia patients across the continuum of care.

Read More